LT4182B - Remedy for treatment of ovarian estrogen dependent conditions - Google Patents

Remedy for treatment of ovarian estrogen dependent conditions Download PDF

Info

Publication number
LT4182B
LT4182B LT96-133A LT96133A LT4182B LT 4182 B LT4182 B LT 4182B LT 96133 A LT96133 A LT 96133A LT 4182 B LT4182 B LT 4182B
Authority
LT
Lithuania
Prior art keywords
antiprogestin
gonadrotropin
releasing hormone
treatment
endometriosis
Prior art date
Application number
LT96-133A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT96133A (en
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of LT96133A publication Critical patent/LT96133A/xx
Publication of LT4182B publication Critical patent/LT4182B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
LT96-133A 1994-02-04 1996-09-04 Remedy for treatment of ovarian estrogen dependent conditions LT4182B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions

Publications (2)

Publication Number Publication Date
LT96133A LT96133A (en) 1997-01-27
LT4182B true LT4182B (en) 1997-06-25

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
LT96-133A LT4182B (en) 1994-02-04 1996-09-04 Remedy for treatment of ovarian estrogen dependent conditions

Country Status (29)

Country Link
US (1) US5681817A (ru)
EP (1) EP0785792B1 (ru)
JP (1) JP3130048B2 (ru)
KR (1) KR970700507A (ru)
CN (1) CN1144486A (ru)
AP (1) AP724A (ru)
AT (1) ATE179610T1 (ru)
AU (1) AU689229B2 (ru)
BG (1) BG62238B1 (ru)
BR (1) BR9506606A (ru)
CA (1) CA2182183C (ru)
CZ (1) CZ291709B6 (ru)
DE (1) DE69509544T2 (ru)
DK (1) DK0785792T3 (ru)
ES (1) ES2132645T3 (ru)
FI (1) FI963036A7 (ru)
GR (1) GR3030164T3 (ru)
HU (1) HUT74622A (ru)
LT (1) LT4182B (ru)
LV (1) LV11782B (ru)
MD (1) MD1432C2 (ru)
NZ (1) NZ281441A (ru)
OA (1) OA10777A (ru)
PL (1) PL178273B1 (ru)
RO (1) RO117420B1 (ru)
RU (1) RU2110274C1 (ru)
SK (1) SK96296A3 (ru)
TJ (1) TJ242B (ru)
WO (1) WO1995020972A1 (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181598C2 (ru) * 1994-07-22 2002-04-27 Дзе Медикал Колледж оф Хэмптон Роудс Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
AU9462498A (en) 1997-10-17 1999-05-10 Mochida Pharmaceutical Co., Ltd. Hysteromyoma remedy containing dienogest as the active ingredient
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
KR20080066095A (ko) * 1999-08-31 2008-07-15 바이엘 쉐링 파마 악티엔게젤샤프트 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP1330257B1 (en) * 2000-10-30 2005-08-31 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
EP2316441A1 (en) * 2005-02-17 2011-05-04 Hadasit Medical Research Services And Development Bisphosphonates for treating endometriosis
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
NZ576274A (en) 2006-10-24 2011-12-22 Repros Therapeutics Inc Compositions and methods for suppressing endometrial proliferation
US20080287408A1 (en) * 2007-05-14 2008-11-20 Drugtech Corporation Endometriosis treatment
ES2467942T3 (es) * 2007-09-20 2014-06-13 Lapidot Medical Import And Marketing Ltd Composiciones y medios para tratar leiomiomas uterinos, leiomioma, mioma, fibroides uterinos, endometriosis, adenomiosis y trastornos relacionados por mifepristona.
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386085A (en) 1981-01-09 1983-05-31 Roussell Uclaf Novel steroids
US4609651A (en) 1983-12-22 1986-09-02 Schering Aktiengesellschaft 11β-arylestradienes, their production, and pharmaceutical preparations containing same
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
US4891368A (en) 1987-12-21 1990-01-02 Schering Aktiengesellschaft Use of antigestagens for softening the nonpregnant cervix
US4957119A (en) 1987-08-08 1990-09-18 Akzo N.V. Contraceptive implant
EP0404283A2 (de) 1989-06-23 1990-12-27 Schering Aktiengesellschaft 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
WO1991014704A2 (en) 1990-03-16 1991-10-03 Applied Research Systems Ars Holding N.V. Treatment of polycystic ovarian disease
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386085A (en) 1981-01-09 1983-05-31 Roussell Uclaf Novel steroids
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
US4609651A (en) 1983-12-22 1986-09-02 Schering Aktiengesellschaft 11β-arylestradienes, their production, and pharmaceutical preparations containing same
US4957119A (en) 1987-08-08 1990-09-18 Akzo N.V. Contraceptive implant
US5088505A (en) 1987-08-08 1992-02-18 Akzo N.V. Contraceptive implant
US4891368A (en) 1987-12-21 1990-01-02 Schering Aktiengesellschaft Use of antigestagens for softening the nonpregnant cervix
EP0404283A2 (de) 1989-06-23 1990-12-27 Schering Aktiengesellschaft 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
WO1991014704A2 (en) 1990-03-16 1991-10-03 Applied Research Systems Ars Holding N.V. Treatment of polycystic ovarian disease
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARR BR ET AL.: "An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.", J CLIN ENDOCRINOL METAB., 1993, pages 1217 - 1223
CHWALISZ, K. ET AL.: "Inhibition of the estradiol mediated endometrial gland formation by the anti-gestagen onapristone in rabbits: Relationship to uterine estrogen receptors", ENDOCRINOLOGY, 1991, pages 312 - 322
GOODMAN AND GILMAN: "The Pharmaceutical Basis of Therapeutics"

Also Published As

Publication number Publication date
AU689229B2 (en) 1998-03-26
FI963036L (fi) 1996-08-01
BR9506606A (pt) 1997-09-09
EP0785792A1 (en) 1997-07-30
HU9601969D0 (en) 1996-09-30
RU2110274C1 (ru) 1998-05-10
BG100766A (bg) 1997-06-30
CZ291709B6 (cs) 2003-05-14
CA2182183C (en) 2003-09-16
DK0785792T3 (da) 1999-10-18
JP3130048B2 (ja) 2001-01-31
RO117420B1 (ro) 2002-03-29
EP0785792A4 (ru) 1997-07-30
US5681817A (en) 1997-10-28
FI963036A0 (fi) 1996-08-01
FI963036A7 (fi) 1996-08-01
BG62238B1 (bg) 1999-06-30
AP724A (en) 1999-01-18
SK96296A3 (en) 1997-07-09
AP9600840A0 (en) 1996-07-31
LV11782A (lv) 1997-06-20
LT96133A (en) 1997-01-27
PL315792A1 (en) 1996-12-09
NZ281441A (en) 1999-09-29
DE69509544T2 (de) 1999-09-02
MD1432C2 (ru) 2000-09-30
CN1144486A (zh) 1997-03-05
GR3030164T3 (en) 1999-08-31
TJ242B (en) 1999-11-24
MD1432B2 (en) 2000-03-31
DE69509544D1 (de) 1999-06-10
ES2132645T3 (es) 1999-08-16
LV11782B (en) 1997-12-20
CA2182183A1 (en) 1995-08-10
KR970700507A (ko) 1997-02-12
AU1838695A (en) 1995-08-21
HUT74622A (en) 1997-01-28
PL178273B1 (pl) 2000-03-31
CZ210396A3 (en) 1997-05-14
JPH09508418A (ja) 1997-08-26
OA10777A (en) 2002-12-23
WO1995020972A1 (en) 1995-08-10
ATE179610T1 (de) 1999-05-15
EP0785792B1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
LT4182B (en) Remedy for treatment of ovarian estrogen dependent conditions
KR100385663B1 (ko) 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물
JP3937240B2 (ja) 黄体ホルモン関連の破綻出血の最小化
EP2079461A1 (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
JPH01502265A (ja) 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出
Jeppsson et al. Short‐term effects of danazol on endometrial histology
RU2181598C2 (ru) Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
BG106442A (bg) Мезопрогестини (прогестерон рецептор модулатори) за лечение и профилактика на хормонозависими доброкачествени гинекологични заболявания
LT4341B (lt) Toninės kiaušidžių estrogeno sekrecijos sureguliavimas pailgintiems terapiniams režimams
US11376263B2 (en) Cyproterone acetate compositions and uses thereof
MXPA97004742A (es) Compuestos con propiedades antagonistas de progesterona y anti-estrogeno para su uso combinado en la anticoncepcion femenina
AU2011203526A1 (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20010202